Neurotech Phase II/III Autism Trial Successfully Meets Primary Endpoint Highlights:
• NTIASD2 Phase II/III clinical trial met the primary endpoint of a statistically significant improvement in severity of illness (CGI-S) at 8 weeks between NTI164 and placebo (p<0.001)
• Children in NTI164 group re-classified from markedly-severely ill (CGI-S: 5.54) at baseline to mild-moderately ill (CGI-S: 3.77) at 8 weeks, a very strong improvement
• Key Secondary endpoints examining adaptive behaviour improvements (Vineland™-3) (p=0.024), CGI-Improvement (p<0.001) social responsiveness (p=0.028), were met with strong treatment-related benefits over placebo
• No serious adverse events recorded, no changes to kidney/liver function over the 8-week period noted, no treatment-related diarrhoea and nausea/vomiting rate lower for NTI164 arm
• Neurotech to accelerate registration-related regulatory discussions given strength of data
• NDIS spend of $6.73 billion to participants with Autism highlights dire need for a safe and effective therapeutic intervention to improve ASD symptoms and reduce healthcare costs
https://www.investi.com.au/api/announcements/nti/3e87a498-65a.pdf
- Forums
- ASX - By Stock
- NTI
- Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint
Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint, page-2
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.26M |
Open | High | Low | Value | Volume |
7.4¢ | 7.4¢ | 7.3¢ | $18.40K | 250.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 159717 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 125286 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 159717 | 0.073 |
6 | 271633 | 0.072 |
4 | 1127811 | 0.071 |
3 | 70980 | 0.070 |
2 | 67535 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 125286 | 4 |
0.076 | 43000 | 1 |
0.077 | 73800 | 1 |
0.078 | 83000 | 1 |
0.079 | 300000 | 1 |
Last trade - 14.11pm 05/07/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |